Manchester Specialty Certificate Examination in Endocrinology and Diabetes

Date: 6th and 7th November 2020

Venue: Virtual Interactive

Organisers: Dr Handrean Soran & Dr Naveed Younis

Course Lead: Dr Handrean Soran (handrean.soran@mft.nhs.uk)

Any enquires please email the course coordinator (ManSce2020@gmail.com)

An example of what the course provides:

  • More than 250 new questions will be discussed in 14 sessions covering the whole curriculum.
  • Access to another ~120 questions from our pool (mock exams included).
  • Focus on clinically relevant areas and popular exam topics.
  • Speaker’s predictions on potential areas of interest.
  • An overall update in endocrinology and diabetes.

Who should attend?

SpRs in Endocrinology and Diabetes, CMTs who plan a career in Endocrinology and Diabetes, Chemical Pathology and Metabolic Medicine trainees, any other UK based or overseas trainee or HCP who is intending to have a career in Diabetes and Endocrinology and/or planning to take the SCE exam or to improve his/her knowledge in Endocrinology and Diabetes. Primary care physicians/trainees and overseas doctors are welcome. The course provides an extensive review and update of all the Endocrinology and Diabetes curriculum.

To reserve your place:

  • Complete the Registration Form.
  • Payment £250.00 before 14th October 2020 (£300 after 14th October 2020): payable via below PayPal account. Please make sure you send your payment once you finish the registration to receive the confirmation . NO confirmation will be sent without receiving the payment.
  • Cancellation policy: registration fee is not refundable if cancellation after 26th October 2020.
  • Only 40 Places are available. First come, first served. Registration will close on 26th October 2020.
  • The link to the online interactive programme will be emailed to the delegates one week in advance. The link allows only one person to join. No other people should be present except the delegate.
  • Delegates should keep the camera open all the time during the course to allow best interaction. If the camera is closed or other conditions breached the delegate may be blocked.

Obesity: A critical risk factor in the COVID‐19 pandemic

Obesity is an emerging independent risk factor for susceptibility to and severity of coronavirus disease 2019 (COVID‐19) caused by the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). Previous viral pandemics have shown that obesity, particularly severe obesity (BMI > 40 kg/m2), is associated with increased risk of hospitalization, critical care admission and fatalities. In this narrative review, we examine emerging evidence of the influence of obesity on COVID‐19, the challenges to clinical management from pulmonary, endocrine and immune dysfunctions in individuals with obesity and identify potential areas for further research. We recommend that people with severe obesity be deemed a vulnerable group for COVID‐19; clinical trials of pharmacotherapeutics, immunotherapies and vaccination should prioritize inclusion of people with obesity.

https://onlinelibrary.wiley.com/doi/full/10.1111/cob.12403

© 2020 The Authors. Clinical Obesity published by John Wiley & Sons Ltd on behalf of World Obesity Federation.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Research from the NW: Vitamin D Status After Bariatric Surgery

Fox A, Slater C, Ahmed B, Ammori BJ, Senapati S, Akhtar K, Ellison J, Summers LKM, Robinson A, New JP, Soran H, Adam S, Syed AA. Vitamin D status after gastric bypass or sleeve gastrectomy over 4 years of follow-up. Obes Surg 2019 | doi:10.1007/s11695-019-04318-0

Vitamin D levels are low in 4 in 5 people with obesity prior to bariatric surgery. Routine supplementation following bariatric surgery reduces rates of deficiency/insufficiency.

15th Northwest Diabetes, Endocrinology and Cardiovascular Update: 8 Dec 2018

What: 15th Northwest Diabetes, Endocrinology and Cardiovascular Update

When: Saturday, 8th Dec 2018

Where: Pendulum Hotel and Manchester Conference Centre, Weston Building, Sackville Street, Manchester, M1 3BB                                                                                                   http://www.manchesterconferencecentre.co.uk

The nearest carpark is situated on Charles street http://www.estates.manchester.ac.uk/services/operationalservices/carparking

To register, please complete the registration form on the following website:

https://www.surveymonkey.co.uk/r/CHH6JS5

For queries: northwest.cpd@gmail.com

Applied for 5 CPD points

Organised by Dr Handrean Soran and Dr Naveed Younis

The sponsors have had no involvement in developing the content of the meeting.

The meeting is free for Health Care professionals, scientists and students.

Limited places available, please book your place as soon as possible.

Provisional Programme

0830–0900 Registration & coffee
0855 Welcome Dr Handrean Soran
  First session
0900–0945 Managing hypertension for general practitioners and physicians

i.        When to treat?

ii.        How to treat?

iii.        What treatment target?

iv.        Should we manage hypertension in patients with diabetes differently?

v.        When to refer to secondary care?

Professor Anthony Heagerty,

University of Manchester, UK

0945-1030 Chronic kidney disease

i.        The impact of chronic kidney disease

ii.        Initial assessment of CKD in primary care

iii.        When to refer patients with CKD to secondary care

iv.        Diabetes nephropathy

When to think beyond diabetes nephropathy?

Initial assessment in primary care

Should we combine ACEIs and ARBs?

Professor Philip Kalra,

Salford Royal NHS Foundation Trust

1030-1115 An update on management of hyperlipidaemia

i.        What is new with LDL cholesterol lowering: PCSK9 monoclonal antibodies

ii.        Hypertriglyceridaemia: how to manage and what is new?

iii.        Diabetes Dyslipidaemia

iv.        Statin intolerance

Dr Handrean Soran,

Manchester University NHS Foundation Trust

1115-1135 Moderated Panel discussion
1135–1215 Sandwich lunch & networking
  Second session
1215-1300 Making sense of clinical guidelines for diabetes in a world of obesity

i.        Treatment options

ii.        Managing diabesity

iii.        When to consider metabolic surgery

Dr Akheel Syed,

Salford Royal NHS Foundation Trust

1300-1345 Managing cardiovascular risk in patients with diabetes: Is there a role for glucose lowering agents?

 

Dr Naveed Younis,

Manchester University NHS Foundation Trust

1345-1400 Nutraceuticals in clinical practice and recent advances TBC
1410-1430  Moderated panel discussion
1430 End
   

 

11th North West Lipid & Atherosclerosis Forum: 18 Sep 2018

What: 11th North West Lipid & Atherosclerosis Forum

When: Tuesday, 18th September 2018

Where: Radisson BLU Hotel, Chicago Avenue, Manchester Airport, Manchester, M90 3RA

Programme

0830 – 0900 Registration & Coffee  
0900 Welcome Dr Handrean Soran
0905 First Session Chairs: Dr Michael France & TBC
0910–0940 Managing hypertension: clinical guidelines and how to individualise treatment? Professor Anthony Heagerty, University of Manchester, UK
0940-1010 A systematic evaluation of glucose lowering therapy and cardiovascular risk: past and present. TBC
1010-1040 Optimizing treatment of Hyperlipidaemia: quantitative evaluation of UK, USA and European guidelines Professor Paul Durrington, University of Manchester, UK
1040-1105 Case presentation

Moderated Panel discussion

Dr Handrean Soran
1105 – 1135 Coffee  and Networking  
1135 Second session          Chairs: Professor Sean Carroll and Dr Basil Iissa
1135-1205 FCS: the disease burden, diagnosis and data from gene therapy. Prof Elisabeth Steinhagen-Thiessen, Berlin, Germany
1205-1335 Recent advances in lipid modification therapy: PCSK9i trials and new therapies for severe hypertriglyceridaemia Dr Handrean Soran, Manchester University Hospital, Manchester, UK
1235-1305 PCSK9, LDL-R and diabetes: from molecular mechanisms to clinical implications. Professor Giuseppe Danilo Norata, Milan, Italy
1305-1315 Panel discussion  
1315 – 1400 Lunch and Networking  
1400 Third session Chairs: Dr Rachelle Donn and Dr Lance Sandle
1400-1430 HDL cholesterol as a therapeutic target: A critical appraisal of previous clinical trials and how can we do better? TBC
 1430-1500 Autoimmunity against HDL/apoA-1: an emergent marker and mediator of cardiovascular risk. Prof Nicolas Vuilleumier, Geneva Faculty of Medicine, Switzerland
1500 – 1515 Coffee  and Networking  
1400 Fourth session Chairs: Dr Dermot Neely, Newcastle, UK & TBC
1510-1540 Lipid lowering nutraceuticals in clinical practice and recent advances Prof Maceij Banach, Warsaw, Poland
1540-1610 Lipoprotein (a) as a cardiovascular risk factor: what HEART UK says? Dr Jaimini  Cegla

Imperial College, London

1420–1440 Coffee and Networking

Feedback/Close

 
1550 END

NWES Annual Meeting: 26 June 2018

What: North West Endocrine Society Annual Meeting

When: 26 June 2018, 13:00 – 17:00

Where: Frank Rifkin Lecture Theatre, Mayo Building, Salford Royal Hospital

PROGRAM

13:00 – 13:30 Welcome and lunch

SESSION 1 CHAIR: Professor David Ray, Manchester Royal Infirmary

13:30 – 13:45 A difficult case of Cushing’s; NW Trainee presentation

13.45 – 14:30 Methionine PET, Dotatate PET, IPSS; Dr Mark Gurnell, Addenbrooke’s Hospital, Cambridge

14:30 – 14:45 Panel discussion: Interpretation of investigations

14:45 – 15:15 Coffee break

SESSION 2 CHAIR: Dr Simon Howell, Royal Preston Hospital

15:15 – 16:00 Endocrine Clinical Case Presentations: Three 15min presentations (will be selected from abstracts submitted)

SESSION 3 CHAIR: Dr Basil Issa, Wythenshawe Hospital

16:00 – 16:40 Debate: This house believes T3 / T4 supplementation has a role

 For: Professor Colin Dayan, University Hospital Wales, Cardiff

 Against: Dr Amit Allahabadia, Sheffield Teaching Hospitals

16:40 – 17:00 Award Ceremony Dr Tara Kearney / Dr Annice Mukherjee

17:00 Close of meeting

Federation of the Royal College of Physicians (UK) CPD credits applied for

Obesity Conference 2017 – Promoting Healthy Lifestyles: 13 Dec 2017

http://www.salford.ac.uk/onecpd/courses/the-obesity-conference-and-exhibition

Two thirds of adults in England are classed as overweight or obese costing the NHS an estimated £6.1 billion a year. With obesity rates increasing among children, this growing public health crisis could become unmanageable in the future without meaningful intervention now. As the NHS strives to put itself on a more sustainable footing, a multifaceted prevention based approach to obesity is needed. This will require greater collaboration between the NHS, local authorities and the private sector as well as measures to address food consumption, lack of exercise and poor lifestyle choices.
Join us for the Obesity Conference 2017 where expert speakers will discuss the latest approaches to the growing crisis in public health. Understand the underlying causes of obesity and how to combat them, observe methods for influencing behaviour and improving public health through prevention and see how different organisations can collaborate to find solutions to the obesity problem.

Contact Eleanor Leach on 0161 295 0115 or Email for more information or to reserve your place.